Company / Current Assets per Share
Arcutis Biotherapeutics, Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.49
FY2025
5-year range
$3.47 / $8.15
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
#155 of 210
Health Care
What the data says
At $3.49, Arcutis Biotherapeutics, Inc.'s current assets per share ranks #155 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 5 years of decline, reaching $3.49.
Based on SEC 10-K filings.
3.49 in FY2025 with a 5-year CAGR of -15.7%.
Declined from $4.77 to $3.49 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -24.0%
- 5-Year CAGR
- -15.7%
- 10-Year CAGR
- -
Sector benchmark
#155 of 210 in Health CareTop 74% of 210This company $3.49 Sector average $134.38
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 0.6% year-over-year.
- Ranks #155 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.49 | +0.6% |
| FY2024 | $3.47 | -27.2% |
| FY2023 | $4.77 | -40.0% |
| FY2022 | $7.95 | -2.5% |
| FY2021 | $8.15 | -0.7% |
| FY2020 | $8.21 | -85.8% |
| FY2019 | $57.77 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026